The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

Joaquin Martinez-Lopez, Satu Mustjoki, Kimmo Porkka, Rebecca B. Klisovic, Dominik Wolf, Lambert Busque, Juan Carlos Hernandez-Boluda, Rene Swanink, Patricia Martin Regueira, Jeffrey H. Lipton

Research output: Contribution to journalLetterScientificpeer-review

Original languageEnglish
JournalLeukemia & lymphoma
Number of pages4
ISSN1042-8194
DOIs
Publication statusE-pub ahead of print - 13 Feb 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • CHRONIC MYELOGENOUS LEUKEMIA
  • T-CELLS
  • EXPANSION

Cite this